[
    {
        "aeid": 891,
        "assayComponentEndpointName": "CEETOX_H295R_11DCORT",
        "exportReady": 1,
        "internalReady": 1,
        "assayComponentEndpointDesc": "Data from the assay component CEETOX_H295R_11DCORT was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_11DCORT, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 11-Deoxycortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",
        "assayFunctionType": "detection of steroid hormone",
        "normalizedDataType": "log2_fold_induction",
        "burstAssay": 0,
        "keyPositiveControl": "Prochloraz;Forskolin",
        "signalDirection": "bidirectional",
        "intendedTargetType": "molecular messenger",
        "intendedTargetTypeSub": "11-Deoxycortisol",
        "intendedTargetFamily": "steroid hormone",
        "intendedTargetFamilySub": "glucocorticoids",
        "cellViabilityAssay": 0,
        "dataUsability": 1,
        "acid": 586,
        "assayComponentName": "CEETOX_H295R_11DCORT",
        "assayComponentDesc": "CEETOX_H295R_11DCORT is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",
        "assayComponentTargetDesc": null,
        "parameterReadoutType": "single",
        "assayDesignType": "inducible reporter",
        "assayDesignTypeSub": "hormone induction",
        "biologicalProcessTarget": "regulation of steroid hormone biosynthetic process",
        "detectionTechnologyType": "Spectrophotometry",
        "detectionTechnologyTypeSub": "Absorbance",
        "detectionTechnology": "HPLC-MS-MS",
        "keyAssayReagentType": "inducer",
        "keyAssayReagent": null,
        "technologicalTargetType": "molecular messenger",
        "technologicalTargetTypeSub": "11-Deoxycortisol",
        "aid": 370,
        "assayName": "CEETOX_H295R",
        "assayDesc": "CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",
        "timepointHr": 48.0,
        "organismId": 9606,
        "organism": "human",
        "tissue": "adrenal gland",
        "cellFormat": "cell line",
        "cellFreeComponentSource": "",
        "cellShortName": "H295R",
        "cellGrowthMode": "adherent",
        "assayFootprint": "microplate: 96-well plate",
        "assayFormatType": "cell-based",
        "assayFormatTypeSub": "cell-based format",
        "contentReadoutType": "multiplexed",
        "dilutionSolvent": "DMSO",
        "dilutionSolventPercentMax": 0.1,
        "asid": 8,
        "assaySourceName": "CEETOX",
        "assaySourceLongName": "Ceetox/OpAns",
        "assaySourceDesc": "Ceetox, a part of Cyprotex, is a Contract Research Organization (CRO) that in coordination with OpAns, an analytical laboratory, provide ADME-tox services.",
        "gene": {
            "geneId": 145,
            "geneName": "nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",
            "description": null,
            "geneSymbol": "NR3C1",
            "organismId": 1,
            "trackStatus": "live",
            "entrezGeneId": 2908,
            "officialSymbol": "NR3C1",
            "officialFullName": "nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",
            "uniprotAccessionNumber": "P04150"
        },
        "assayList": {
            "name": "EDSP steroidogenesis",
            "description": "Steroidogenesis pathway assays used in EDSP"
        },
        "citations": {
            "doi": "doi: 10.1093/toxsci/kfw002",
            "url": "https://pubmed.ncbi.nlm.nih.gov/26781511/",
            "pmid": 26781511,
            "title": "High-Throughput Screening of Chemical Effects on Steroidogenesis Using H295R Human Adrenocortical Carcinoma Cells",
            "author": "Karmaus AL, Toole CM, Filer DL, Lewis KC, Martin MT",
            "citation": "Karmaus AL, Toole CM, Filer DL, Lewis KC, Martin MT. High-Throughput Screening of Chemical Effects on Steroidogenesis Using H295R Human Adrenocortical Carcinoma Cells. Toxicol Sci. 2016 Apr;150(2):323-32. doi: 10.1093/toxsci/kfw002. Epub 2016 Jan 18. PMID: 26781511; PMCID: PMC4809454.",
            "otherId": "0",
            "citationId": 245,
            "otherSource": ""
        }
    }, 
    {
        "aeid": 663,
        "assayComponentEndpointName": "NVS_GPCR_rAdra1_NonSelective",
        "exportReady": 1,
        "internalReady": 1,
        "assayComponentEndpointDesc": "Data from the assay component NVS_GPCR_rAdra1_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. \r\nUsing a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1a. \r\nFurthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. \r\nTo generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",
        "assayFunctionType": "binding",
        "normalizedDataType": "percent_activity",
        "burstAssay": 0,
        "keyPositiveControl": "Phentolamine mesylate",
        "signalDirection": "loss",
        "intendedTargetType": "protein",
        "intendedTargetTypeSub": "receptor",
        "intendedTargetFamily": "gpcr",
        "intendedTargetFamilySub": "rhodopsin-like receptor",
        "cellViabilityAssay": 0,
        "dataUsability": 1,
        "acid": 400,
        "assayComponentName": "NVS_GPCR_rAdra1_NonSelective",
        "assayComponentDesc": "NVS_GPCR_rAdra1_NonSelective is one of one assay component(s) measured or calculated from the NVS_GPCR_rAdra1_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.",
        "assayComponentTargetDesc": "Changes to scintillation counting signals produced from the receptor-ligand binding of the key ligand [[3H]-7-Methoxy-Prazosin] are indicative of a change in receptor function and kinetics for the Norway rat adrenoceptor alpha 1A [GeneSymbol:Adra1a | GeneID:29412 | Uniprot_SwissProt_Accession:P43140].",
        "parameterReadoutType": "single",
        "assayDesignType": "binding reporter",
        "assayDesignTypeSub": "radioligand binding",
        "biologicalProcessTarget": "receptor binding",
        "detectionTechnologyType": "Radiometry",
        "detectionTechnologyTypeSub": "Scintillation counting",
        "detectionTechnology": "Filter-based radiodetection",
        "keyAssayReagentType": "ligand",
        "keyAssayReagent": "[3H]-7-Methoxy-Prazosin",
        "technologicalTargetType": "protein",
        "technologicalTargetTypeSub": "receptor",
        "aid": 214,
        "assayName": "NVS_GPCR_rAdra1_NonSelective",
        "assayDesc": "NVS_GPCR_rAdra1_NonSelective is a biochemical, single-readout assay that uses extracted gene-proteins from Rat forebrain membranes in a tissue-based cell-free assay. Measurements were taken 1 hour after chemical dosing in a 48-well plate.",
        "timepointHr": 1.0,
        "organismId": 10116,
        "organism": "rat",
        "tissue": "brain",
        "cellFormat": "tissue-based cell-free",
        "cellFreeComponentSource": "Rat forebrain membranes",
        "cellShortName": "NA",
        "cellGrowthMode": "NA",
        "assayFootprint": "microplate: 48-well plate",
        "assayFormatType": "biochemical",
        "assayFormatTypeSub": "protein single format",
        "contentReadoutType": "single",
        "dilutionSolvent": "DMSO",
        "dilutionSolventPercentMax": 0.0,
        "asid": 5,
        "assaySourceName": "NVS",
        "assaySourceLongName": "Novascreen",
        "assaySourceDesc": "NovaScreen, part of PerkinElmer, a human and environmental health company, provides a large diverse suite of cell-free binding and biochemical assays.",
        "gene": {
            "geneId": 419,
            "geneName": "adrenoceptor alpha 1A",
            "description": null,
            "geneSymbol": "Adra1a",
            "organismId": 3,
            "trackStatus": "live",
            "entrezGeneId": 29412,
            "officialSymbol": "Adra1a",
            "officialFullName": "adrenoceptor alpha 1A",
            "uniprotAccessionNumber": "P43140"
        },
        "assayList": null,
        "citations": {
            "doi": "",
            "url": "http://www.ncbi.nlm.nih.gov/pubmed/2879884",
            "pmid": 2879884,
            "title": "Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: competition studies with [3H]prazosin and [3H]idazoxan",
            "author": "Reader TA, Brière R, Grondin L",
            "citation": "Reader TA, Brière R, Grondin L. Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: competition studies with [3H]prazosin and [3H]idazoxan. J Neural Transm. 1987;68(1-2):79-95. PubMed PMID: 2879884.",
            "otherId": "0",
            "citationId": 73,
            "otherSource": ""
        }
}
]
